▲ 1.16%
prev close
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Congressional Trades
8
All tracked trades
Members Trading
4
Unique members
Net Activity
-4
2 buys · 6 sells
Members Who Traded This Stock
8 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-09-14 | IQVIQVIA Holdings Inc. | Sell | $15,001 - $50,000 | 25d ago | — | |
| 2026-09-08 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 25d ago | — | |
| 2026-09-03 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 25d ago | — | |
| 2026-03-16 | IQVIQVIA Holdings Inc. | Sell | $50,001 - $100,000 | 200d ago | — | |
| 2025-12-29 | IQVIQVIA Holdings Inc. | Buy | $15,001 - $50,000 | 277d ago | — | |
| 2025-10-02 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 339d ago | — | |
| 2025-05-15 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 507d ago | — | |
| 2025-04-08 | IQVIQVIA Holdings Inc. | Buy | $15,001 - $50,000 | 530d ago | — |
2026-09-14
Kevin Hern
IQV
Amount
$15,001 - $50,000
Filed
25d ago
2026-09-08
Kevin Hern
IQV
Amount
$1,001 - $15,000
Filed
25d ago
2026-09-03
Kevin Hern
IQV
Amount
$1,001 - $15,000
Filed
25d ago
2026-03-16
Kevin Hern
IQV
Amount
$50,001 - $100,000
Filed
200d ago
2025-12-29
Markwayne Mullin
IQV
Amount
$15,001 - $50,000
Filed
277d ago
2025-10-02
John Boozman
IQV
Amount
$1,001 - $15,000
Filed
339d ago
2025-05-15
Rob Bresnahan
IQV
Amount
$1,001 - $15,000
Filed
507d ago
2025-04-08
Rob Bresnahan
IQV
Amount
$15,001 - $50,000
Filed
530d ago
Recent News
Powered by Polygon.io
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions
Trade Timeline
Congressional activity, newest first
Kevin Hern
2026-09-14 · Sale
$15,001 - $50,000
Kevin Hern
2026-09-08 · Sale
$1,001 - $15,000
Kevin Hern
2026-09-03 · Sale
$1,001 - $15,000
Kevin Hern
2026-03-16 · Sale
$50,001 - $100,000
Markwayne Mullin
2025-12-29 · Purchase
$15,001 - $50,000
John Boozman
2025-10-02 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-05-15 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-04-08 · Purchase
$15,001 - $50,000